(RTTNews) - Nikkei reported that Japan's Takeda Pharmaceutical Co. (TKPHY.PK, TKPHF.PK) is planning to buyout Abbott Laboratories'
(ABT) stake in the 50-50 joint venture, TAP Pharmaceutical Productions Inc. The report further noted that Abbott's stake in the venture is valued at 300 billion yen to 500 billion yen. This transaction would increase Takeda sales, the report added.
For comments and feedback: contact editorial@rttnews.com